ArticleCancers2023

A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety.

Mara Mantiero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.